Genomics and proteomics are two subfields of molecular biology that study the structure and function of living organisms at a molecular level. Genomics is the study of an organism’s full set of genes in order to understand the genetic processes that control their growth and behavior. Proteomics is the study of an organism’s proteins, which are the molecular machines that control the functioning of cells in the body. Both disciplines are important to gaining insight into the workings of the human body, from the genetic basis of disease to better understanding how food and drugs are metabolized. Genomics is the science of characterizing and studying an organism’s entire genetic context, which consists of its DNA, RNA, and proteins. By determining the condensed sequence of an organisms’ genome, scientists are able to create detailed information on the genetic basis of its phenotype and learn more about the molecular functioning of its gene products. By understanding gene-disease associations, scientists can identify mutated genes associated with various diseases and develop treatments based on this knowledge. Genomics also helps us understand an organism’s evolutionary history and the degree of gene flow from one generation to the next. Proteomics is the science of systematically analyzing all of the proteins in a single organism in order to gain a better understanding of the cellular processes and biological pathways that are active in the organism. Proteins are the large molecular machines that make up the majority of the functioning cell, and by studying their interactions with other molecules, scientists can gain insight into how different diseases develop and spread throughout an organism’s body. Proteomics also informs our understanding of how drugs can be used to target a specific protein, and can aid in drug development by helping to identify mechanisms of action for potential therapeutic candidates. In conclusion, Genomics and Proteomics are powerful tools for biologists to study and understand the functioning of living organisms at the molecular level.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States